Trial of Point-of-treatment Xpert MTB/RIF Assay
NCT01554384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1472
Last updated 2013-06-06
Summary
Xpert MTB/RIF assay is a novel automated molecular tool for the diagnosis of TB. Xpert can detect TB genetic material in sputum samples as well as test for genetic resistance to rifampicin providing results within 2 hours. Xpert received WHO endorsement in December 2010. There is limited data on the impact of Xpert on time-to-treatment and TB-related patient morbidity in primary care clinics. No studies have yet evaluated Xpert performed at the point-of-treatment (POT) i.e. in primary care clinic location. The investigators hypothesize that one sputum GeneXpert MTB/RIF assay performed at the POT will improve time-to-diagnosis, time-to-treatment and TB related patient morbidity for patients with suspected TB presenting to primary level TB clinics in high HIV prevalent settings.
Conditions
Interventions
- PROCEDURE
-
Xpert MTB/RIF assay
Automated nucleic-acid amplification test (fully integrated) test for TB
- PROCEDURE
-
Smear microscopy
Smear microscopy involve sputum smear with either ziehl-neelsen or auramine-O staining of slides and light or fluorescence microscopy reading
Sponsors & Collaborators
-
Biomedical Research and Training Institute
collaborator OTHER -
University of Zimbabwe
collaborator OTHER -
University of Zambia
collaborator OTHER -
Medical Research Council, South Africa
collaborator OTHER -
Mbeya medical research program
collaborator UNKNOWN - collaborator OTHER
-
Radboud University Medical Center
collaborator OTHER -
University of Cape Town Lung Institute
collaborator OTHER -
University of Cape Town
lead OTHER
Principal Investigators
-
Keertan Dheda, MD PhD · University of Cape Town
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-07-31
Countries
- South Africa
- Zambia
- Zimbabwe
Study Locations
More Related Trials
-
Accuracy and Feasibility of Xpert Ultra
NCT03072576 ·Status: COMPLETED
-
Sensitivity and Specificity of Xpert MTB/RIF Ultra
NCT06058065 ·Status: NOT_YET_RECRUITING
-
Improving TB Diagnosis and Treatment Through Basic, Applied and Health Systems Research
NCT03356925 ·Status: COMPLETED ·Phase: NA
-
Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB
NCT06392594 ·Status: NOT_YET_RECRUITING
-
Multidrug Resistance in Newly Diagnosed TB Patient
NCT06700577 ·Status: NOT_YET_RECRUITING
-
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19
NCT05220163 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
GeneXpert Performance Evaluation for Linkage to Tuberculosis Care
NCT03044158 ·Status: COMPLETED ·Phase: NA
-
Assessing the Ability of the T-SPOT®.TB Test
NCT03929705 ·Status: COMPLETED
-
Xpert MTB/RIF Ultra Trial
NCT07135622 ·Status: COMPLETED ·Phase: NA
-
Acceptability and Feasibility of Home-based TB Testing
NCT04973371 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Accuracy of a Novel Xpert Cartridge
NCT02251327 ·Status: COMPLETED
-
Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis
NCT06409572 ·Status: NOT_YET_RECRUITING
-
Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis
NCT04433195 ·Status: UNKNOWN ·Phase: NA
-
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
NCT01990274 ·Status: COMPLETED ·Phase: NA
-
Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis
NCT03423550 ·Status: UNKNOWN
-
DIAgnostics for Multidrug Resistant Tuberculosis in Africa
NCT03303963 ·Status: COMPLETED
-
Study About Drug Resistance of Mycobacterium Tuberculosis
NCT07169149 ·Status: NOT_YET_RECRUITING
-
Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil
NCT01363765 ·Status: COMPLETED ·Phase: PHASE4
-
Gene Xpert Diagnosis of TB Using Tracheal Aspirates From Intensive Care Unit (ICU) Patients
NCT01530568 ·Status: COMPLETED ·Phase: NA
-
Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis (TBM) in Maharaj Nakorn Chiang Mai Hospital
NCT05781646 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests
NCT02252198 ·Status: COMPLETED
-
TB-CAPT MTB/XDR Study
NCT04567368 ·Status: ACTIVE_NOT_RECRUITING
-
Assessing the Ability of the T-SPOT®.TB Test (IQ)
NCT03973970 ·Status: COMPLETED
-
2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.
NCT03988933 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis
NCT04666311 ·Status: COMPLETED